Mildly abnormal general movement quality in infants is associated with higher Mead acid and lower arachidonic acid and shows a U-shaped relation with the DHA/AA ratio

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 1, 2010, Pages 15-20

  van Goor, S A ^a   Schaafsma, A ^b   Erwich, J J H M ^a   Dijck Brouwer, D A J ^a   Muskiet, F A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FrieslandCampina Leeuwarden ^*  (Netherlands)

Author keywords

Arachidonic acid; Brain development; Docosahexaenoic acid; General movements; Insulin resistance; Insulin sensitivity; Long chain polyunsaturated fatty acids; Mead acid; Neurodevelopment; Pregnancy

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; LINOLEIC ACID; PLACEBO;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE LEVEL; FAT INTAKE; FATTY ACID METABOLISM; FEMALE; HUMAN; HUMAN CELL; INFANT; INSULIN SENSITIVITY; MATERNAL CARE; MATERNAL NUTRITION; MOTHER CHILD RELATION; MOTOR DYSFUNCTION; NERVOUS SYSTEM DEVELOPMENT; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THIRD TRIMESTER PREGNANCY;

8,11,14-EICOSATRIENOIC ACID; ADULT; ALGORITHMS; ARACHIDONIC ACIDS; BIOLOGICAL MARKERS; BREAST FEEDING; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTES; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; INFANT; MALE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STATISTICS AS TOPIC;

EID: 73949141659     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.11.004     Document Type: Article

References (48)

1. Innis S.M. Fatty acids and early human development. Early Hum. Dev. 83 (2007) 761-766
2. Serhan C.N., and Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153 Suppl 1 (2008) S200-S215
3. S.A. van Goor, D.A. Dijck-Brouwer, B. Doornbos, Supplementation of DHA but not DHA+AA during pregnancy and lactation increases the rate of mildly abnormal general movements, Submitted for publication.
4. Hadders-Algra M. General movements: a window for early identification of children at high risk for developmental disorders. J. Pediatr. 145 (2004) S12-S18
5. Hadders-Algra M. Putative neural substrate of normal and abnormal general movements. Neurosci. Biobehav. Rev. 31 (2007) 1181-1190
6. McCann J.C., and Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 82 (2005) 281-295
7. Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 36 (2008) 101-109
8. Simmer K., Patole S.K., and Rao S.C. Long chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. (2008) CD000376
9. Levant B., Ozias M.K., and Carlson S.E. Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats. Physiol. Behav. 89 (2006) 196-204
10. Jacobson J.L., Jacobson S.W., Muckle G., Kaplan-Estrin M., Ayotte P., and Dewailly E. Beneficial effects of a polyunsaturated fatty acid on infant development: evidence from the inuit of arctic Quebec. J. Pediatr. 152 (2008) 356-364
11. Hadders-Algra M., Mavinkurve-Groothuis A.M., Groen S.E., Stremmelaar E.F., Martijn A., and Butcher P.R. Quality of general movements and the development of minor neurological dysfunction at toddler and school age. Clin. Rehabil. 18 (2004) 287-299
12. Touwen B.C., Huisjes H.J., Jurgens-van der Zee A.D., Bierman-van Eendenburg M.E., Smrkovsky M., and Olinga A.A. Obstetrical condition and neonatal neurological morbidity. An analysis with the help of the optimality concept. Early Hum. Dev. 4 (1980) 207-228
13. Muskiet F.A., van Doormaal J.J., Martini I.A., Wolthers B.G., and van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J. Chromatogr. 278 (1983) 231-244
14. Volmer M., Meiborg G., and Muskiet F.A. Simultaneous capillary gas chromatographic profiling of medium- and long-chain fatty acid methyl esters with split injection. Correction for injection-related discrimination by the 'bracketing' method. J. Chromatogr. 434 (1988) 385-394
15. Bouwstra H., Dijck-Brouwer D.A., Decsi T., et al. Relationship between umbilical cord essential fatty acid content and the quality of general movements of healthy term infants at 3 months. Pediatr. Res. 59 (2006) 717-722
16. Muskiet F.A., van Goor S.A., Kuipers R.S., et al. Long-chain polyunsaturated fatty acids in maternal and infant nutrition. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 135-144
17. Helland I.B., Smith L., Saarem K., Saugstad O.D., and Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111 (2003) e39-e44
18. Fokkema M.R., Smit E.N., Martini I.A., Woltil H.A., Boersma E.R., and Muskiet F.A. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 345-356
19. Hornstra G., Van Houwelingen A.C., Simonis M., and Gerrard J.M. Fatty acid composition of umbilical arteries and veins: possible implications for the fetal EFA-status. Lipids 24 (1989) 511-517
20. Widdowson E.M. Growth and composition of the fetus and newborn. Biol. Gestation (1968) 1-49
21. Dancis J., Jansen V., Kayden H.J., Schneider H., and Levitz M. Transfer across perfused human placenta II. Free fatty acids. Pediatr. Res. 7 (1973) 192-197
22. Coleman R.A. The role of the placenta in lipid metabolism and transport. Semin. Perinatol. 13 (1989) 180-191
23. Portman O.W., Behrman R.E., and Soltys P. Transfer of free fatty acids across the primate placenta. Am. J. Physiol. 216 (1969) 143-147
24. Cleland L.G., Neumann M.A., Gibson R.A., Hamazaki T., Akimoto K., and James M.J. Effect of dietary n-9 eicosatrienoic acid on the fatty acid composition of plasma lipid fractions and tissue phospholipids. Lipids 31 (1996) 829-837
25. Dijck-Brouwer D.A., Hadders-Algra M., Bouwstra H., et al. Impaired maternal glucose homeostasis during pregnancy is associated with low status of long-chain polyunsaturated fatty acids (LCP) and essential fatty acids (EFA) in the fetus. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 85-87
26. Wijendran V., Bendel R.B., Couch S.C., Philipson E.H., Cheruku S., and Lammi-Keefe C.J. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids 35 (2000) 927-931
27. V.J.B. Huiskes, R.S. Kuipers, F.V. Velzing-Aarts, D.A. Dijck-Brouwer, J. van der Meulen, F.A. Muskiet, Higher de novo synthesized fatty acids and lower omega3- and omega6-long-chain polyunsaturated fatty acids in umbilical vessels of women with preeclampsia and high fish intakes, Prostaglandins Leukot. Essent. Fatty Acids (2009)
28. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., and Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005) 1343-1351
29. Jump D.B. Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41 (2004) 41-78
30. Haggarty P. Effect of placental function on fatty acid requirements during pregnancy. Eur. J. Clin. Nutr. 58 (2004) 1559-1570
31. K.F.A.M. Hulshof, M.C. Ocke, C.T.M. van Rossum, Results of the national food consumption survey 2003, RIVM Report 350030002/2004, 2004.
32. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60 (2006) 502-507
33. Al M.D., Van Houwelingen A.C., Kester A.D., Hasaart T.H., de Jong A.E., and Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 74 (1995) 55-68
34. Von Schacky C., and Harris W.S. Cardiovascular risk and the omega-3 index. J. Cardiovasc. Med. 8 Suppl 1 (2007) S46-S49
35. Hsieh A.T., Anthony J.C., Diersen-Schade D.A., et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr. Res. 61 (2007) 537-545
36. Farquharson J., Cockburn F., Patrick W.A., Jamieson E.C., and Logan R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 340 (1992) 810-813
37. Makrides M., Neumann M.A., Byard R.W., Simmer K., and Gibson R.A. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60 (1994) 189-194
38. Jamieson E.C., Farquharson J., Logan R.W., et al. Infant cerebellar gray and white matter fatty acids in relation to age and diet. Lipids 34 (1999) 1065-1071
39. Farooqui A.A., Horrocks L.A., and Farooqui T. Modulation of inflammation in brain: a matter of fat. J. Neurochem. 101 (2007) 577-599
40. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296 (2006) 1885-1899
41. Church M.W., Jen K.L., Dowhan L.M., Adams B.R., and Hotra J.W. Excess and deficient omega-3 fatty acid during pregnancy and lactation cause impaired neural transmission in rat pups. Neurotoxicol. Teratol. 30 (2008) 107-117
42. Scott D.T., Janowsky J.S., Carroll R.E., Taylor J.A., Auestad N., and Montalto M.B. Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits?. Pediatrics 102 (1998)
43. Lauritzen L., Jorgensen M.H., Olsen S.F., Straarup E.M., and Michaelsen K.F. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod. Nutr. Dev. 45 (2005) 535-547
44. Diau G.Y., Hsieh A.T., Sarkadi-Nagy E.A., Wijendran V., Nathanielsz P.W., and Brenna J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 3 nr 11 (2005)
45. Chalon S., Delion-Vancassel S., Belzung C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 128 (1998) 2512-2519
46. Calabrese E.J., and Baldwin L.A. Hormesis: the dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 175-197
47. O'Keefe J.H., Bybee K.A., and Lavie C.J. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J. Am. Coll. Cardiol. 50 (2007) 1009-1014
48. Hayes D.P. Adverse effects of nutritional inadequacy and excess: a hormetic model. Am. J. Clin. Nutr. 88 (2008) 578S-581S